SEC Filings - Kezar Life Sciences, Inc.

Filing date	Form	Description	Filing Group	View
May 11, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0000950170-23-021203.pdf 0000950170-23-021203.rtf 0000950170-23-021203.xls EX-101.PRE - XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
May 11, 2023	10-Q	Quarterly report which provides a continuing view of a company's financial position	Quarterly Filings	View HTML 0000950170-23-021257.pdf 0000950170-23-021257.rtf 0000950170-23-021257.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
May 11, 2023	S-8	Securities offered to employees pursuant to employee benefit plans	Registration Statements	View HTML 0000950170-23-021322.pdf 0000950170-23-021322.rtf 0000950170-23-021322.xls
May 5, 2023	EFFECT	EFFECT	Other	View HTML 9999999995-23-001305.pdf 9999999995-23-001305.rtf 9999999995-23-001305.xls
April 27, 2023	DEFA14A	Additional proxy soliciting materials - definitive	Proxy Filings	View HTML 0000950170-23-015252.pdf 0000950170-23-015252.rtf 0000950170-23-015252.xls
April 27, 2023	DEF 14A	Official notification to shareholders of matters to be brought to a vote ("Proxy")	Proxy Filings	View HTML 0000950170-23-015247.pdf 0000950170-23-015247.rtf 0000950170-23-015247.xls
April 27, 2023	8-K	Report of unscheduled material events or corporate event	Current Reports	View HTML 0000950170-23-015303.pdf 0000950170-23-015303.rtf 0000950170-23-015303.xls EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
April 21, 2023	SC 13G	A statement of beneficial ownership of common stock by certain persons	Other	View HTML 0001193125-23-108561.pdf 0001193125-23-108561.rtf 0001193125-23-108561.xls
April 17, 2023	PRE 14A	A preliminary proxy statement providing notification matters to be brought to a vote	Proxy Filings	View HTML 0000950170-23-013070.pdf 0000950170-23-013070.rtf 0000950170-23-013070.xls
March 14, 2023	POSASR	POSASR	Other	View HTML 0001193125-23-070125.pdf 0001193125-23-070125.rtf 0001193125-23-070125.xls

Data provided by Kaleidoscope.